These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 20166680

  • 1. Complement protein C1q recognizes enzymatically modified low-density lipoprotein through unesterified fatty acids generated by cholesterol esterase.
    Biro A, Ling WL, Arlaud GJ.
    Biochemistry; 2010 Mar 16; 49(10):2167-76. PubMed ID: 20166680
    [Abstract] [Full Text] [Related]

  • 2. Modified low density lipoproteins differentially bind and activate the C1 complex of complement.
    Biró A, Thielens NM, Cervenák L, Prohászka Z, Füst G, Arlaud GJ.
    Mol Immunol; 2007 Feb 16; 44(6):1169-77. PubMed ID: 16938346
    [Abstract] [Full Text] [Related]

  • 3. Enzymatically modified low-density lipoprotein is recognized by c1q and activates the classical complement pathway.
    Arlaud GJ, Biro A, Ling WL.
    J Lipids; 2011 Feb 16; 2011():376092. PubMed ID: 21490800
    [Abstract] [Full Text] [Related]

  • 4. Enzymatic modification of low-density lipoprotein in the arterial wall: a new role for plasmin and matrix metalloproteinases in atherogenesis.
    Torzewski M, Suriyaphol P, Paprotka K, Spath L, Ochsenhirt V, Schmitt A, Han SR, Husmann M, Gerl VB, Bhakdi S, Lackner KJ.
    Arterioscler Thromb Vasc Biol; 2004 Nov 16; 24(11):2130-6. PubMed ID: 15345515
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The role of dietary oxidized cholesterol and oxidized fatty acids in the development of atherosclerosis.
    Staprans I, Pan XM, Rapp JH, Feingold KR.
    Mol Nutr Food Res; 2005 Nov 16; 49(11):1075-82. PubMed ID: 16270280
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Native, amyloid fibrils and beta-oligomers of the C-terminal domain of human prion protein display differential activation of complement and bind C1q, factor H and C4b-binding protein directly.
    Sjöberg AP, Nyström S, Hammarström P, Blom AM.
    Mol Immunol; 2008 Jun 16; 45(11):3213-21. PubMed ID: 18406463
    [Abstract] [Full Text] [Related]

  • 10. Possible protective role for C-reactive protein in atherogenesis: complement activation by modified lipoproteins halts before detrimental terminal sequence.
    Bhakdi S, Torzewski M, Paprotka K, Schmitt S, Barsoom H, Suriyaphol P, Han SR, Lackner KJ, Husmann M.
    Circulation; 2004 Apr 20; 109(15):1870-6. PubMed ID: 15037531
    [Abstract] [Full Text] [Related]

  • 11. Effect of modified C-reactive protein on complement activation: a possible complement regulatory role of modified or monomeric C-reactive protein in atherosclerotic lesions.
    Ji SR, Wu Y, Potempa LA, Liang YH, Zhao J.
    Arterioscler Thromb Vasc Biol; 2006 Apr 20; 26(4):935-41. PubMed ID: 16456095
    [Abstract] [Full Text] [Related]

  • 12. Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: effects of apolipoprotein E deficiency and probucol or phytosterol treatment.
    Moghadasian MH, Nguyen LB, Shefer S, Salen G, Batta AK, Frohlich JJ.
    Metabolism; 2001 Jun 20; 50(6):708-14. PubMed ID: 11398149
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Biochemical and functional characterization of the interaction between pentraxin 3 and C1q.
    Nauta AJ, Bottazzi B, Mantovani A, Salvatori G, Kishore U, Schwaeble WJ, Gingras AR, Tzima S, Vivanco F, Egido J, Tijsma O, Hack EC, Daha MR, Roos A.
    Eur J Immunol; 2003 Feb 20; 33(2):465-73. PubMed ID: 12645945
    [Abstract] [Full Text] [Related]

  • 17. Low density lipoprotein-cholesteryl ester-derived linoleic acid is mainly incorporated into the phospholipid component of the macrophages.
    Li Q, Fuhrman B, Aviram M.
    Isr J Med Sci; 1995 Aug 20; 31(8):474-8. PubMed ID: 7635696
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.